Economic outcomes of maintenance gefitinib for locally advanced/metastatic non-small-cell lung cancer with unknown EGFR mutations: a semi-Markov model analysis.
about
Economic evaluation of first-line and maintenance treatments for advanced non-small cell lung cancer: a systematic reviewTrial-Based Cost-Utility Analysis of Icotinib versus Gefitinib as Second-Line Therapy for Advanced Non-Small Cell Lung Cancer in ChinaQuality of pharmacoeconomic research in China: A systematic reviewPrognostic factors in patients with skeletal-related events at non-small-cell lung cancer diagnosis.Economic Considerations in the Use of Novel Targeted Therapies for Lung Cancer: Review of Current Literature.
P2860
Economic outcomes of maintenance gefitinib for locally advanced/metastatic non-small-cell lung cancer with unknown EGFR mutations: a semi-Markov model analysis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Economic outcomes of maintenan ...... a semi-Markov model analysis.
@ast
Economic outcomes of maintenan ...... a semi-Markov model analysis.
@en
type
label
Economic outcomes of maintenan ...... a semi-Markov model analysis.
@ast
Economic outcomes of maintenan ...... a semi-Markov model analysis.
@en
prefLabel
Economic outcomes of maintenan ...... a semi-Markov model analysis.
@ast
Economic outcomes of maintenan ...... a semi-Markov model analysis.
@en
P2093
P2860
P1433
P1476
Economic outcomes of maintenan ...... a semi-Markov model analysis.
@en
P2093
Chongqing Tan
Gannong Chen
Liubao Peng
Xiaohui Zeng
Xiaomin Wan
Yunhua Wang
P2860
P304
P356
10.1371/JOURNAL.PONE.0088881
P407
P577
2014-02-20T00:00:00Z